HESKA Feline UltraNasal FVRC Vaccine

This page contains information on HESKA Feline UltraNasal FVRC Vaccine for veterinary use.
The information provided typically includes the following:
  • HESKA Feline UltraNasal FVRC Vaccine Indications
  • Warnings and cautions for HESKA Feline UltraNasal FVRC Vaccine
  • Direction and dosage information for HESKA Feline UltraNasal FVRC Vaccine

HESKA Feline UltraNasal FVRC Vaccine

This treatment applies to the following species:
Manufacturer: Heska

Feline Rhinotracheitis-Calici Vaccine

Modified Live Virus, Code 16C1.22

For Use in Cats and Kittens Only

Description and General Information: Feline Rhinotracheitis-Calici Vaccine, MLV is designed for nasal administration. Each of the viruses are widespread and are common disease causing agents of cats.

HESKA Feline UltraNasal FVRC Vaccine Indications

Recommended for the vaccination of healthy, susceptible cats against feline herpesvirus-1 (the cause of feline rhinotracheitis) and feline calicivirus. Cats can be vaccinated with a single dose at 12 weeks of age. If cats are vaccinated at less than 12 weeks of age, a second vaccination should be administered at 12 - 16 weeks of age. Annual revaccination is recommended.

Precautions

Store out of direct sunlight at a temperature between 35°F and 45°F (2°C - 7°C). Use the entire contents of the vaccine when first opened. Do not vaccinate pregnant animals. Burn containers and all unused contents.

In rare instances, reactions can occur due to unusual sensitivity following use of this product. In such cases, administer epinephrine as an antidote. The vaccine will not protect against disease in the face of incubating feline herpesvirus, or feline calicivirus infection. Therefore, only healthy cats should be considered as candidates for vaccination.

Transient sneezing for one or more days after vaccination is not uncommon. A small number of cats may experience other mild post-vaccination side effects including ocular and/or nasal discharge, GI signs (such as vomiting) or, in rare instances, nasal or oral ulcers. These signs are usually mild and clear without treatment.

Contains gentamicin and fungistat as preservatives.

Dosage and Administration

Administer a single 0.2 ml dose intranasally, divided into both nostrils. NOTE: Use a new dropper for each cat vaccinated. No needles are necessary to administer the vaccine. This vaccine is NOT intended for intramuscular or subcutaneous injection.

STEP 1: Remove the cap and rubber stopper from one vial of sterile diluent and one vial of lyophilized vaccine.

STEP 2: Using the nasal dropper, transfer the sterile diluent (0.2 ml) to the lyophilized vaccine vial.

STEP 3: Mix the vaccine in the vial with a gentle swirling motion.

STEP 4: Once dissolved, immediately withdraw the rehydrated vaccine into the nasal dropper.

STEP 5: Vaccinate the cat by placing the vaccine equally in each nostril. Avoid touching the nose with the dropper.

Contains 20 (1 dose) vials of dry vaccine, 20 (0.2 ml) vials of sterile diluent and 20 droppers.

Keep refrigerated at a temperature between 35°F and 45°F. Store out of direct sunlight.

Heska Corporation

1-800-GO HESKA

Fort Collins, Colorado 80525

U.S. Vet. License No. 213

©2004 Heska Corporation

04177

904102

NAC No.: 14820121

HESKA CORPORATION
3760 ROCKY MOUNTAIN AVENUE, LOVELAND, CO, 80538
Telephone:   970-493-7272
Fax:   970-619-3008
Information/Order Desk:   800-GO-HESKA
Website:   www.heska.com
Email:   market@heska.com
Every effort has been made to ensure the accuracy of the HESKA Feline UltraNasal FVRC Vaccine information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web5)